Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

<< Previous

Bullboard Posts

Next >>

Post by PLITheOneon Mar 29, 2020 1:52pm

114 Views

Post# 30857753

IF

If Thomvest’s greed prevented them from capitalizing on this current situation. They downplayed the value of this company while stealing it from investors. Their attempt to devalue this company while extracting value out to grow somewhere later has blown up in their face. They could care less about patients or investors. Their intentional delays and screwing investors has come back to roust.

Plasma cure

<< Previous

Bullboard Posts

Next >>

A potential breakthrough in spinal cord and optic nerve injury treatment